Study of SHR6390 in Renal Insufficiency and Healthy Subjects

NCT05515289 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: SHR6390

Sponsor

Jiangsu HengRui Medicine Co., Ltd.